Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

Frontiers Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia

Signal Transduction and Targeted Therapy期刊最新论文, 化学/材料, - X-MOL

Targeted therapy for fusion-driven high-risk acute leukemia - ScienceDirect

Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study - The Lancet Haematology

SEC Filing — Kura Oncology, Inc.

Menin Inhibitors in Acute Myeloid Leukemia: An Overview of “Encouraging” Early Data

Targeting the undruggable: menin inhibitors ante portas

Menin Inhibitors: Promising New Drug Treatment for Aggressive Leukemia

Acute promyelocytic leukemia - Wikipedia

A Novel Approach Towards a Vaccine for Relapsing Acute Myeloid Leukemia: Q&A with Dr. Karin Gaensler - BroadcastMed

First-in-Human Study of Revumenib Shows 'Promising' Activity in Acute Leukemias

Transcription factor abnormalities in B-ALL leukemogenesis and treatment: Trends in Cancer

A Box of Chemistry to Inhibit the MEN1 Tumor Suppressor Gene Promoting Leukemia - Ozyerli‐Goknar - 2021 - ChemMedChem - Wiley Online Library